AIM ImmunoTech Inc.(AIM)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
AIM is scheduled to report on Nov 16, 2026, usually after the market closes. Analysts expect EPS of -$0.14.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±13.5%).
Did the stock rise after good news?
The next-day move after each of its last 5 EPS beats and 6 misses.
In plain words: it beat expectations 5 times, but the stock still fell 3 of those 5 times.
- Aug '26Missed▼ -10.3%
- May '26Missed▲ +64.0%
- Mar '26Beat▼ -21.4%
- Nov '25Missed▼ -7.6%
- Aug '25Beat▲ +3.1%
- May '25Beat▼ -11.1%
- Nov '24Beat▼ -12.0%
- Aug '24Beat▲ +7.4%
- May '24Missed▼ -2.5%
- Apr '24Missed▲ +4.3%
- Nov '23Missed▲ +4.4%
Clear beats and misses with a known reaction only. What counts as a beat
Why did AIM fall after beating earnings?
6 of AIM's last 11 reactions went against the EPS result. What stands out in each:
AIM beat EPS estimates in 5 quarters, and the stock still closed lower the next day 3 times. In 2 of the 3 where we have price data, the stock had already run up before the report.
- Mar 27, 2026EPS beat +53.2%stock -21.4% next day
- It opened 1.4% higher, but sellers took over and it closed -21.4%.
- May 15, 2025EPS beat +37.5%stock -11.1% next day
- It had risen 200.0% in the 20 trading sessions before the report, so good news may already have been priced in.
- Nov 14, 2024EPS beat +20.6%stock -12.0% next day
- It had risen 4.2% in the final week before the report, so good news may already have been priced in.
- It opened 4.0% lower as soon as trading resumed.
Rose despite an EPS miss (3 of 6)
- May 15, 2026EPS missed -86.5%stock +64.0% next day
- It had already fallen 54.5% in the 20 trading sessions before the report, so weak results may have been expected.
- It opened 12.0% higher as soon as trading resumed.
- Apr 1, 2024EPS missed -88.1%stock +4.3% next day
- It opened 4.3% higher as soon as trading resumed.
- Nov 14, 2023EPS missed -47.0%stock +4.4% next day
- It had already fallen 11.8% in the 20 trading sessions before the report, so weak results may have been expected.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was AIM's earnings move already priced in?
AIM's move in the month before each of its last 11 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 11 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does AIM hold its opening gap after earnings?
AIM's opening move after each report and where it closed that day.
In 6 reports AIM opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 6 times (33%), and fully reversed 2 times. Gaps up faded 2 of 4; gaps down recovered 0 of 2.
- Aug 7, 2026HeldOpened -10.3%, closed -10.3%
- May 15, 2026HeldOpened +12.0%, closed +64.0%
- Mar 27, 2026ReversedOpened +1.4%, closed -21.4%
- Nov 14, 2024HeldOpened -4.0%, closed -12.0%
- May 15, 2024ReversedOpened +5.0%, closed -2.5%
- Apr 1, 2024HeldOpened +4.3%, closed +4.3%
What the history says
- It fell after 3 of its 5 EPS beats (60%): beating estimates has not been enough on its own.
AIM earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | After close | -$0.12 | -$0.43 | -258.3% | -10.34% | -10.34% |
| May 15, 2026 | After close | -$0.37 | -$0.69 | -86.5% | +64.00% | 0.00% |
| Mar 27, 2026 | After close | -$0.94 | -$0.44 | +53.2% | -21.43% | -21.43% |
| Nov 17, 2025 | After close | -$0.98 | -$1.57 | -60.2% | -7.64% | -9.72% |
| Aug 14, 2025 | After close | -$7.99 | -$3.68 | +53.9% | +3.11% | -2.33% |
| May 15, 2025 | After close | -$7.99 | -$4.99 | +37.5% | -11.11% | 0.00% |
| Mar 27, 2025 | Before open | -$8.99 | -$9.99 | -11.1% | — | — |
| Nov 14, 2024 | After close | -$8.66 | -$6.88 | +20.6% | -12.00% | -28.00% |
| Aug 14, 2024 | After close | -$12.32 | -$3.00 | +75.6% | +7.41% | +14.81% |
| May 15, 2024 | After close | -$10.99 | -$11.99 | -9.1% | -2.50% | +2.50% |
| Apr 1, 2024 | Before open | -$14.99 | -$28.19 | -88.1% | +4.26% | +2.13% |
| Nov 14, 2023 | After close | -$10.99 | -$16.15 | -47.0% | +4.44% | 0.00% |
Consensus for the next report: EPS -$0.14, revenue $0.00.
AIM Earnings FAQ
Answers computed from AIM ImmunoTech Inc.'s reported history
AIM is scheduled to report on Nov 16, 2026, usually after the market closes. Analysts expect EPS of -$0.14.
Over the last 12 quarters with a usable EPS surprise, AIM beat the consensus estimate 5 times (42%), missed 7 and landed in line 0. It has missed estimates in each of the last 2 counted quarters.
Across its last 11 quarters with a measured reaction, AIM moved an average of ±13.5% in the first session after reporting. It closed higher 46% of the time; the largest gain was 64.0% and the largest drop -21.4%.
AIM fell in the first session after 3 of its last 5 EPS beats (60%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 2 of the 3 of those falls where price data is available, the stock had already risen before the report.
Across its last 11 quarters with price data, AIM moved an average of -3.6% in the 20 trading sessions before reporting and was higher in 27% of them. After a run-up of 3% or more (3 quarters), it fell the next day 67% of the time, averaging -5.7%. After a drop of 3% or more (8 quarters), it rose the next day 50% of the time, averaging +4.4%. This describes past reports; it is not a forecast.
In 6 reports AIM opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 6 times (33%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · AIM: 12 reported quarters, latest Aug 7, 2026. Information only, not investment advice.
Looking for more on AIM?
Price charts, forecast, fundamentals and risk pages for AIM are not on Tickzen yet. You can run a full stock analysis now.
Run the AIM Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun